Knowledge base Updated 2 November 2026 1 views

Placebo Effect

A genuine change in a person's condition produced by the psychosocial context of a treatment — expectation, conditioning, ritual and the clinical relationship — rather than by any specific active ingredient.

Definition

A distinction that most discussion collapses and should not:

Placebo response: the total change observed in a placebo group, which includes natural history, regression to the mean, and reporting effects.
Placebo effect: the part attributable to the psychosocial context.

Separating them requires a no-treatment control arm, which most trials do not have. Most claims about the size of the placebo effect are actually about the placebo response and are therefore inflated.

Nocebo is the same process producing harm: negative expectation generating adverse effects, well documented in trials where placebo-arm participants report the specific side effects listed on the consent form.

History

Beecher's 1955 paper, The Powerful Placebo, claimed around a third of patients respond to placebo and shaped belief for fifty years. Its methodology has since been criticised heavily, principally for attributing to placebo everything that happened in the placebo arm.

Hróbjartsson and Gøtzsche's Cochrane reviews, comparing placebo with no treatment, found little effect on most objective outcomes and a modest effect on continuous subjective outcomes, especially pain. That is a much narrower claim than the one in circulation.

Theory

Two mechanisms with good evidence, and they are not the same.

Expectancy: conscious anticipation of benefit. Manipulable by verbal suggestion, and the mechanism behind most placebo analgesia. Endogenous opioid involvement is demonstrated directly — naloxone blocks a substantial part of placebo analgesia.

Conditioning: repeated pairing of a treatment cue with a pharmacological effect, such that the cue alone produces a response. This is the dominant mechanism for immune and endocrine placebo responses, which are not accessible to conscious expectation.

Context factors that reliably modulate the effect: the practitioner's warmth and confidence, the elaborateness of the ritual, price and branding, route of administration, and whether the person knows they are receiving treatment. Open-label versus hidden administration studies show the same drug is measurably less effective when given without the patient's knowledge.

Research

Best-supported in pain, nausea, depression, Parkinsonian motor symptoms and irritable bowel syndrome. Weak or absent for objective outcomes such as tumour size, infection resolution or lung function measured objectively — a distinction that matters enormously and is routinely blurred.

Open-label placebo is the most surprising line of work: placebos given with full disclosure that they are inert have shown benefits in IBS, chronic low back pain and cancer-related fatigue. Effects are modest, several trials are small, and replication is ongoing, but the finding challenges the assumption that deception is required.

Nocebo effects are substantial in practice and are a documented cause of statin discontinuation, among other examples.

Applications

Trial design, where the no-treatment arm is the only way to estimate the effect properly and where blinding integrity is rarely checked.

Clinical practice: the context of care is an active component. How a treatment is explained, the confidence with which it is offered, and the relationship it is offered within change outcomes measurably. Framing of side-effect information changes nocebo rates, which creates a genuine tension with informed consent that has no clean resolution.

Ethically, open-label placebo and context optimisation are ways to use the effect without deception.

Criticism

The effect is routinely overstated, because response is reported as effect.
Objective outcomes largely do not respond, and popular accounts imply otherwise.
Open-label findings are early: small samples, unblinded by design, and susceptible to demand characteristics.
The concept is heterogeneous. Expectancy, conditioning, regression and reporting bias are different things sharing one word.
It is used to dismiss. Calling a treatment a placebo is often a way of ending a conversation rather than a claim about mechanism, and it does not follow that a placebo-mediated benefit is not a benefit.

References

Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews, CD003974.
Benedetti, F. (2014). Placebo Effects (2nd ed.). Oxford University Press.
Kaptchuk, T. J., et al. (2010). Placebos without deception. PLoS ONE, 5(12), e15591.
Colloca, L., & Barsky, A. J. (2020). Placebo and nocebo effects. New England Journal of Medicine, 382(6), 554-561.
Beecher, H. K. (1955). The powerful placebo. JAMA, 159(17), 1602-1606.

Written for PsychologyOrbit and reviewed before publishing. It is a summary for professionals and students, not clinical guidance, and it is not a substitute for the primary sources listed above.